Caveat Emptor

In her personal health column in the New York Times, Jane Brody writes that for consumers who are using direct-to-consumer genetic tests to discover their medical risks, testing is "fraught with potential dangers." Those dangers range from receiving false reassurance to a lack of federal oversight to uncertainty about clinical validity.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.